PubMed ID:
35587997
Public Release Type:
Journal
Publication Year: 2022
Affiliation: 1). Harrington Heart and Vascular Institute, University Hospitals Cleveland Medical Center, Cleveland, OH
2). Minneapolis Heart Institute, Minneapolis, MN
3). Department of Medicine-Hypertension, university Hospitals Cleveland Medical Center, Cleveland, OH
DOI:
https://doi.org/10.1002/ejhf.2543
Authors:
Hajjari J,
Janus SE,
Al-Kindi SG,
Karnib M,
Chami T,
Mously H,
Carneiro H,
Badhwar AK,
Mahboob Rahman M
Request IDs:
21517
Studies:
Chronic Renal Insufficiency Cohort Study
Heart failure (HF) is one of the leading causes of cardiovascular morbidity and mortality in the ever-growing population of patients with chronic kidney disease (CKD). Despite the well described association, development of tools to enhance early diagnosis and initiate treatment in the CKD population has been lacking. We sought to study the feasibility of a multi-variable biomarker approach to predict incident HF risk in CKD.